Pharmaceutical Solutions Provider Skila - Recognized as IT Company of the Year by NJTC
Morris Plains, N.J., November 30, 2004 - Skila, A
Sela2 Company, has announced that they have been awarded "Software/IT
Company of the Year" at the 2004 NJTC Gala Awards held November 5,
2004 in East Brunswick, New Jersey.
The NJTC Gala Awards are given each year to New Jersey companies of varying
sizes and industries that represent the State's best and brightest.
"We are honored by this award and the recognition by the NJTC,"
commented Moish Tov, CEO of Skila. "It affirms our mission to our
Pharmaceutical Industry partners to provide best in class solutions that
enable them to uniquely respond to the critical business challenges they
are facing today."
"The winners this year truly represent the continued excellence
of New Jersey technology companies," said Maxine Ballen, CEO of the
New Jersey Technology Council. "This year's Suspense Awards had the
tightest competition yet; they have certainly lived up to their name."
All winners and finalists were selected from a pool of nominations provided
by the member companies and individuals of the New Jersey Technology Council.
For information about the Council, please visit our website at http://www.NJTC.org
About The NJTC
The New Jersey Technology Council represents technology-intensive industries and the institutions and service companies that support them by providing:
Networking opportunities
Access to financing sources
Information
Public policy advocacy
Business support
Recognition of the industries and their leaders
Founded in 1996, NJTC has more than 1,100 member companies. Each year
the council offers its members more than 80 conferences, panel discussions,
technology tours, and networking events throughout New Jersey.
About Skila
Skila, a BelHealth investment company, is a global technology and services company specializing in fully managed "Solution" as-a-Service (SaaS) product launch lifecycle management and engagement / relationship management solutions for the healthcare industry. Skila’s solutions address the broad needs of global marketing, medical, market access, executive and alliance management teams that include a unique methodology, robust technology and key continuous services for effectively managing global product launches, key opinion leader relationships, market access / managed care, business performance, competitive intelligence, and key partnerships and alliances.
Having developed strong relationships with a broad number of global pharmaceutical companies, Skila’s solutions have been deployed in 61 countries, supporting numerous global brands and more than 10 million user interactions. Skila’s long-standing commitment and understanding of customers’ needs has resulted in the exponential growth and adoption of our methodology, technology and continuous services as the business platform of choice for our clients.
BelHealth is a private healthcare investment fund. For more info, visit www.belhealth.com.
